Libo Yang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 18
- HER2/EGFR in Cancer Research 10
- Co-authors
- Hong Bu (22 shared papers)Yan Qiu (5 shared papers)Bin Zhao (4 shared papers)Ai‐Xin Zhu (8 shared papers)Quan‐Qing Xu (6 shared papers)Yong Yang (3 shared papers)Guoying Zhang (3 shared papers)Ru Yan (5 shared papers)
- Journals
- CrystEngComm (4 papers)PLoS ONE (4 papers)Breast Cancer Research and Treatment (3 papers)Organic Chemistry Frontiers (2 papers)Journal of Clinical Pathology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Libo Yang
60 papers receiving 894 citations
Peers
Comparison fields: 5 of 103
- Cancer Research 299
- Oncology 243
- Inorganic Chemistry 109
- Molecular Biology 383
- Pulmonary and Respiratory Medicine 119
Countries citing papers authored by Libo Yang
This map shows the geographic impact of Libo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Yang more than expected).
Fields of papers citing papers by Libo Yang
This network shows the impact of papers produced by Libo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Yang. The network helps show where Libo Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 84 | |
| 2 | 2023 | 41 | |
| 3 | 2020 | 34 | |
| 4 | 2020 | 32 | |
| 5 | 2021 | 32 | |
| 6 | 2018 | 31 | |
| 7 | 2015 | 31 | |
| 8 | 2021 | 27 | |
| 9 | 2016 | 27 | |
| 10 | 2017 | 27 | |
| 11 | 2019 | 26 | |
| 12 | 2024 | 26 | |
| 13 | 2018 | 26 | |
| 14 | 2019 | 25 | |
| 15 | 2023 | 24 | |
| 16 | 2013 | 24 | |
| 17 | 2017 | 24 | |
| 18 | 2022 | 24 | |
| 19 | 2018 | 24 | |
| 20 | 2018 | 23 |
About Libo Yang
Libo Yang is a scholar working on Molecular Biology, Oncology, Cancer Research, Inorganic Chemistry and Radiology, Nuclear Medicine and Imaging, having authored 65 papers that have together received 906 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Breast Cancer Treatment Studies (10 papers), Metal-Organic Frameworks: Synthesis and Applications (8 papers), Breast Lesions and Carcinomas (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer-related molecular mechanisms research (5 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Covalent Organic Framework Applications (3 papers). The work is most often cited by research in Cancer Research (299 citations), Oncology (243 citations), Inorganic Chemistry (109 citations), Molecular Biology (383 citations) and Pulmonary and Respiratory Medicine (119 citations). Libo Yang has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Hong Bu, Yan Qiu, Bin Zhao, Ai‐Xin Zhu, Quan‐Qing Xu, Yong Yang, Guoying Zhang, Ru Yan, Ruiqian Li and Shaobin Jia. Their work appears in journals such as CrystEngComm, PLoS ONE, Breast Cancer Research and Treatment, Organic Chemistry Frontiers and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.